- Home
- MVF vs HRTX Comparison
MVF vs HRTX Comparison
Compare MVF & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVF
- HRTX
- Stock Information
- Founded
- MVF 1988
- HRTX 1983
- Country
- MVF United States
- HRTX United States
- Employees
- MVF N/A
- HRTX N/A
- Industry
- MVF Investment Bankers/Brokers/Service
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- MVF Finance
- HRTX Health Care
- Exchange
- MVF Nasdaq
- HRTX Nasdaq
- Market Cap
- MVF 375.5M
- HRTX 325.0M
- IPO Year
- MVF N/A
- HRTX 1987
- Fundamental
- Price
- MVF $6.66
- HRTX $1.81
- Analyst Decision
- MVF
- HRTX Strong Buy
- Analyst Count
- MVF 0
- HRTX 2
- Target Price
- MVF N/A
- HRTX $5.00
- AVG Volume (30 Days)
- MVF 162.8K
- HRTX 925.2K
- Earning Date
- MVF 01-01-0001
- HRTX 08-11-2025
- Dividend Yield
- MVF 4.11%
- HRTX N/A
- EPS Growth
- MVF N/A
- HRTX N/A
- EPS
- MVF N/A
- HRTX N/A
- Revenue
- MVF N/A
- HRTX $148,518,000.00
- Revenue This Year
- MVF N/A
- HRTX $12.08
- Revenue Next Year
- MVF N/A
- HRTX $12.57
- P/E Ratio
- MVF N/A
- HRTX N/A
- Revenue Growth
- MVF N/A
- HRTX 12.43
- 52 Week Low
- MVF $5.85
- HRTX $1.04
- 52 Week High
- MVF $7.19
- HRTX $2.88
- Technical
- Relative Strength Index (RSI)
- MVF 59.92
- HRTX 40.01
- Support Level
- MVF $6.43
- HRTX $1.66
- Resistance Level
- MVF $6.67
- HRTX $1.90
- Average True Range (ATR)
- MVF 0.05
- HRTX 0.08
- MACD
- MVF 0.02
- HRTX -0.02
- Stochastic Oscillator
- MVF 95.83
- HRTX 38.46
About MVF Blackrock MuniVest Fund Inc.
Blackrock Munivest Fund Inc is an investment management firm. Its investment objective is to provide current income exempt from regular U.S. federal income tax. The company invests in various sectors such as Health; Transportation; Utilities; Education; Tobacco; Housing and others.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.